| Authors: |
Duggal G; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Oxford StemTech, The Oxford Science Park, Oxford, UK. Electronic address: galbha.duggal@oxfordstemtech.com., Li X; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK., Pettingill P; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK., Lalic T; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK., Gupta SK; Global Portfolio & Project Management, Oncology R&D, Cambridge, UK., Høgsbro CF; Department of Neurology, Faculty of Health and Medical Sciences, Danish Headache Center, Glostrup Hospital, University of Copenhagen, Glostrup, Denmark., Volpato V; UK Dementia Research Institute, Department of Psychological Medicine and Clinical Neuroscience, Cardiff University, Cardiff, UK., Webber C; UK Dementia Research Institute, Department of Psychological Medicine and Clinical Neuroscience, Cardiff University, Cardiff, UK., Bowden R; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK., Charou D; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK., Arunasalam K; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK., Maresca M; Discovery Biology, Discovery Sciences IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Hicks R; Bioanalytical and Biomarker Labs, Thermofisher Scientific, Gothenburg, Sweden., Chintawar S; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Oxford StemTech, The Oxford Science Park, Oxford, UK., Cader MZ; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Oxford StemTech, The Oxford Science Park, Oxford, UK. Electronic address: zameel.cader@ndcn.ox.ac.uk. |
